Patiromer use in patients with heart failure: lessons and clinical considerations from the DIAMOND trial

Eur J Heart Fail. 2022 Oct;24(10):1744-1747. doi: 10.1002/ejhf.2684. Epub 2022 Sep 20.

Authors

Javed Butler^{1

2}, Tariq Jamal Siddiqi², Stefan D Anker^{3

4

5}

Affiliations

¹ Department of Medicine, Baylor University Medical Center, Dallas, TX, USA.
² Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
³ Department of Cardiology and Berlin Institute of Health Center for Regenerative Therapies, Berlin, Germany.
⁴ German Centre for Cardiovascular Research partner site Berlin, Berlin, Germany.
⁵ Charité Universitätsmedizin Berlin, Berlin, Germany.

No abstract available

MeSH terms

Heart Failure* / chemically induced
Heart Failure* / complications
Heart Failure* / drug therapy
Humans
Hyperkalemia* / chemically induced
Polymers / therapeutic use
Potassium
Renal Insufficiency, Chronic*

Substances

patiromer
Polymers
Potassium